Beta Bionics to Present at the Bank of America Securities Health Care Conference

Rhea-AI Summary

Beta Bionics (BBNX), a company focused on diabetes management solutions, has announced its participation in the upcoming Bank of America Securities Health Care Conference. The presentation is scheduled for Tuesday, May 13, 2025, at 12:35 PM ET (9:35 AM PT) in Las Vegas. Interested parties can access the live audio webcast through the company's investor relations website under the "Events & Presentations" section at investors.betabionics.com. The presentation recording will be archived on the website for future viewing.

News Market Reaction – BBNX

+0.81%

+0.81% Session move

In the trading session that priced this news, BBNX gained 0.81%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

IRVINE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at the Bank of America Securities Health Care Conference in Las Vegas on Tuesday, May 13, 2025 at 12:35 pm Eastern Time (9:35 am Pacific Time).

A live audio webcast of the presentation will be available on the Company’s website in the “Investors—Events & Presentations” section at https://investors.betabionics.com, and will be archived there for future replay following the event.

About Beta Bionics

Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared insulin delivery device that autonomously determines every insulin dose and offers the potential to substantially improve overall outcomes across broad populations of PWD. To learn more, visit www.betabionics.com.

Investor Relations:
Blake Beber
Head of Investor Relations
ir@betabionics.com

Media and Public Relations:
Karen Hynes
Vice President of Marketing
media@betabionics.com

Source: Beta Bionics, Inc.

FAQ

When is Beta Bionics (BBNX) presenting at the Bank of America Securities Health Care Conference?

Beta Bionics is presenting on Tuesday, May 13, 2025, at 12:35 PM Eastern Time (9:35 AM Pacific Time).

Where can I watch Beta Bionics' (BBNX) Bank of America Securities conference presentation?

The presentation can be accessed via live audio webcast on Beta Bionics' investor relations website at investors.betabionics.com under the 'Events & Presentations' section.

Will Beta Bionics' (BBNX) Bank of America Securities conference presentation be available for replay?

Yes, the presentation will be archived on Beta Bionics' investor relations website for future replay following the event.

Where is the Bank of America Securities Health Care Conference being held in 2025?

The Bank of America Securities Health Care Conference is being held in Las Vegas.